Anrate Recombinant Human Albumin (rHSA) – Vaccine Protectant, Stabilizer & Auxiliary Material for Vaccine Manufacturing & Preparation
Recombinant Human Serum Albumin (HSA) is synthesized by hepatic parenchymal cells and is the most abundant protein in human plasma. It exerts a variety of physiological and pharmacological functions, including antioxidant activity, lipase-like activity, and osmotic pressure regulation, and is capable of binding and transporting numerous endogenous and exogenous compounds.
Anrate Recombinant Human Albumin is a recombinant human serum albumin expressed and purified from Pichia pastoris via gene recombination technology. It contains no animal-derived components and carries no risk of blood-borne viral infection, with excellent batch-to-batch stability. It can act as an excipient to replace plasma-derived albumin, and has a wide range of applications in the biopharmaceutical industry: it serves as a component of cell therapy culture media, a pharmaceutical excipient for biopharmaceutical use, a carrier for gene delivery and therapeutic agents, a raw material for in vitro diagnostics, a substrate for vaccine production and preparation, and an embedding agent for medical devices.
Industry Common Challenges
Vaccine antigens, viral vectors and bioactive proteins are core raw materials for vaccine manufacturing, which own extreme temperature sensitivity and weak molecular structural stability. In the whole vaccine preparation, fermentation production, lyophilization processing, cross-region cold chain distribution and long-term warehouse storage process, common defects including antigen degradation, protein aggregation and bioactivity loss will occur easily. These problems directly damage vaccine safety, vaccine formulation stability, immune performance and standard vaccine shelf life for commercial vaccine biological products.
Product Overview
Anrate supplies professional biopharma excipients customized for global vaccine manufacturing, acting as high-performance vaccine protectant and vaccine stabilizer for full vaccine preparation workflows. With proprietary molecular encapsulation and hydrogen bond activity-locking technology, Anrate vaccine stabilizer protects active vaccine antigens comprehensively, improves vaccine safety and vaccine structural stability stably, and effectively extends vaccine validity period for biopharmaceutical vaccine manufacturers worldwide.
Core Product Value
I.Improve Finished Vaccine Safety
Anrate high-grade vaccine protectant adopts animal-origin-free, ultra-low endotoxin and non-sensitizing raw materials, fully compliant with EP, USP and global biotech production standards. The professional vaccine stabilizer reduces soluble impurity precipitation and degradation byproducts, optimizes finished vaccine biological safety, and meets global vaccine R&D, performance test and commercial filing requirements.
II.Enhance Vaccine Preparation Stability
As a top-rated vaccine stabilizer for vaccine preparation, Anrate biopharmaceutical excipient withstands temperature fluctuation, mechanical shearing force and liquid pH fluctuation during vaccine mass production and international logistics. It locks natural antigen molecular structure to prevent vaccine bioactivity failure, with strong compatibility with inactivated vaccine, recombinant vaccine, subunit vaccine and viral vector vaccine for commercial biological product production.
III.Extend Vaccine Validity Period
Anrate vaccine protectant slows down intrinsic molecular degradation of vaccine active components, relieves long-term storage activity attenuation, breaks conventional cold storage limitations, remarkably extends vaccine validity period and commercial vaccine shelf life, cuts vaccine finished product scrappage and reduces overall supply chain cost for global vaccine manufacturing enterprises.
Anrate Product Competitive Advantages
GMP Standard Production: Mass production in line with GMP guidelines, high raw material purity, fully compatible with aseptic production workshop process of vaccine manufacturers;
High Formula Compatibility: No original production process adjustment required, simple feeding operation and low application cost;
One-stop Technical Service: Professional formula optimization support, match vaccine enterprises with preparation upgrading and regulatory document supporting service;
Anrate is a reliable manufacturer and supplier of professional vaccine preparation excipients, focusing on qualified vaccine protectant and vaccine stabilizer supply for global biotech and vaccine manufacturing plants. We support full-cycle services covering vaccine lab R&D, pilot trial and large-scale commercial vaccine manufacturing.
Disclaimer
Intended solely for laboratory research, scientific trials and industrial manufacturing. Not for clinical use, nor for administration to humans or animals.
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
